Microbot Medical Inc.

MBOT | $0.8701 -2.24% -2.29% 93K

(0.0% 1d) (-25.2% 1m) (-47.6% 1y) (0.0% 2d) (-4.4% 3d) (-16.5% 7d) (-60.11% volume)
Earnings Calendar: 2022-11-14
Market Cap: $ 12,528,539
http://www.microbotmedical.com
Sec Filling | Patents | 11 employees

(US) Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system, and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.

autonomous endoscopy treatment

add to watch list Paper trade email alert is off

Press-releases

Microbot Medical Shares Status Following Recent Geopolitical Events
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
MBOT | $0.8701 -2.24% -2.29% 93K

Health Technology

| -14.85% | O: 4.95% H: 3.77% C: -2.83%
medical

Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US
Published: 2024-02-05 (Crawled : 12:30) - globenewswire.com
MBOT | $0.8701 -2.24% -2.29% 93K

Health Technology

| -28.93% | O: 1.65% H: 1.63% C: 0.81%
fda approval medical application trial

Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters
Published: 2024-01-30 (Crawled : 12:30) - globenewswire.com
MBOT | $0.8701 -2.24% -2.29% 93K

Health Technology

| -38.35% | O: -2.51% H: 1.1% C: -2.94%
medical

Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study
Published: 2024-01-18 (Crawled : 12:30) - globenewswire.com
MBOT | $0.8701 -2.24% -2.29% 93K

Health Technology

| -31.75% | O: 0.79% H: 6.31% C: 5.51%
first medical study submission

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
Published: 2023-12-29 (Crawled : 13:00) - globenewswire.com
MBOT | $0.8701 -2.24% -2.29% 93K

Health Technology

| -58.05% | O: -25.37% H: 16.34% C: 7.19%
nasdaq million medical

Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met
Published: 2023-12-28 (Crawled : 12:30) - globenewswire.com
MBOT | $0.8701 -2.24% -2.29% 93K

Health Technology

| -34.85% | O: 21.21% H: 39.37% C: 28.12%
pre-clinical positive medical results study

Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic
Published: 2023-12-14 (Crawled : 13:00) - globenewswire.com
MBOT | $0.8701 -2.24% -2.29% 93K

Health Technology

| -30.08% | O: 0.81% H: 10.78% C: 2.42%
liberty health system collaboration medical

Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study
Published: 2023-12-07 (Crawled : 13:00) - globenewswire.com
MBOT | $0.8701 -2.24% -2.29% 93K

Health Technology

| -28.93% | O: 4.96% H: 0.0% C: -3.94%
pre-clinical medical milestone study submission

Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities
Published: 2023-11-21 (Crawled : 14:30) - globenewswire.com
HAE | $81.24 -2.66% -1.65% 850K

Health Technology

| -2.04% | O: 0.24% H: 0.59% C: -0.82%
BSX | $67.33 -0.13% -0.31% 7M

Health Technology

| 23.63% | O: 0.37% H: 1.26% C: 1.21%
MBOT | $0.8701 -2.24% -2.29% 93K

Health Technology

| -37.23% | O: -1.46% H: 5.19% C: 0.0%
commercial medical

Microbot Medical Successfully Completed Integral Part of the Verification and Validation Process
Published: 2023-11-13 (Crawled : 13:30) - globenewswire.com
MBOT | $0.8701 -2.24% -2.29% 93K

Health Technology

| -36.76% | O: -2.21% H: 2.26% C: 0.75%
medical

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001493152-24-007870	4	2024-02-26	2024-02-22	Buy	A	17500	17500
0001493152-24-007872	4	2024-02-26	2024-02-22	Buy	A	17500	17500